MDR-30X

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMDR-30X
Drug Alias NameMDR-30X
ClassificationOther
Mechanisms of ActionImmunomodulatorsCell replacements
TargetsNot applicable
Therapy Area/IndicationsBone marrow transplant rejectionHemoglobinopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedeor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedeor Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBone marrow transplant rejectionHemoglobinopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A